Drugs / GBS Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02270944 Comparator | Nov 2014 → Apr 2015 | group B streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GBS Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02270944 ↗ |
| Modality | Vaccine | “Liquid formulation of a vaccine containing polysaccharide capsules from serotypes Ia, Ib, and III of the Group B Streptococcus” NCT02270944 ↗ |